Indonesia COVID-19

The approval of the Zifivax jab is set to add further momentum to the country's vaccine rollout, but serious obstacles remain

But Southeast Asia's largest country is not quite out of the woods yet.

The Indonesian government needs to jettison its hopes of a miracle cure to COVID-19, and listen to the advice of epidemiologists and health experts.

In recent weeks, the region has seen more than twice as many deaths from the coronavirus than North America.

President Joko Widodo said that the development of infrastructure and "quality human capital" will remain priorities for the remainder of his second term.

Just as cases are beginning to ease in densely populated Java and Bali, they are rising elsewhere.

The pandemic has highlighted deep-rooted problems in health service. Medical workers voicing out their concerns have put governments on the defensive.

Will mounting evidence about the limited efficacy of Chinese-made vaccines spell the end for Beijing's vaccine diplomacy?

There are alarming reports that the Delta variant has penetrated more remote regions of the archipelago.

At least half of the region's 11 nations have seen record daily infection counts over the past week.

The offer comes as the Southeast Asian nation struggles to contain an exponential increase in COVID-19 infections.